doc, eski & co.
Seite 1 von 1 Neuester Beitrag: 07.01.04 15:15 | ||||
Eröffnet am: | 07.01.04 14:39 | von: Parocorp | Anzahl Beiträge: | 5 |
Neuester Beitrag: | 07.01.04 15:15 | von: Parocorp | Leser gesamt: | 8.551 |
Forum: | Börse | Leser heute: | 4 | |
Bewertet mit: | ||||
LONDON (CBS.MW) -- Starr Surgical Co. (STAA) said it's cooperating with the FDA to address their concerns in a Warning Letter as part of the approval process for Starr's Implantable Contact Lens. Starr said said it believes costs that "will be incurred to implement corrective actions to successfully resolve these issues will not be material." It said: "We believe that the actions required to correct the issues cited by the FDA in its Warning Letter can be successfully resolved in a reasonable time-frame."
AirNet Communications Expects to Exceed Q4 Revenue Forecast
Wednesday January 7, 8:06 am ET
Company Expects Revenue to More than Double When Compared to 4Q02
MELBOURNE, Fla.--(BUSINESS WIRE)--Jan. 7, 2004--AirNet Communications Corporation (Nasdaq:ANCC - News), the technology leader in software defined base station products for wireless communications, today announced that it expects to exceed its fourth quarter 2003 revenue forecast.
During the Company's 3rd quarter conference call, revenue for the fourth quarter was estimated to be in the range of $3.0 - 4.5 million dollars. Based on preliminary unaudited results, fourth quarter revenue is expected to exceed $4.5
million dollars, an improvement of at least 125% compared to the $2.0M in revenue reported for the fourth quarter of fiscal year 2002.